Prosus India's Mixed Returns in H1FY25

CosmicTaco · 2024-12-02T16:50:22.228641+05:30

- Prosus India's portfolio sees mixed IRR, with PharmEasy (-38%) and Eruditus (14%) underperforming, while ElasticRun (23%), Swiggy, and PayU (20-21%) perform better. - Prosus aims to increase capital deployment in India, anticipating several IPOs in the next 12-18 months. - CEO Fabricio Bloisi emphasizes India's potential, highlighting recent investments in Mintifi and Vastu Housing Finance. Source: [Moneycontrol](https://www.moneycontrol.com/news/business/startup/prosus-india-pharmeasy-and-eruditus-deliver-low-returns-elasticrun-swiggy-payu-fare-better-in-h1fy25-12880959.html)

Prosus India's portfolio sees mixed IRR, with PharmEasy (-38%) and Eruditus (14%) underperforming, while ElasticRun (23%), Swiggy, and PayU (20-21%) perform better.
Prosus aims to increase capital deployment in India, anticipating several IPOs in the next 12-18 months.
CEO Fabricio Bloisi emphasizes India's potential, highlighting recent investments in Mintifi and Vastu Housing Finance.

Source: Moneycontrol